Skip to content

to see the Effect of Drakshadi Siddha Aschyotana in Pittaj Abhishyanda that is Conjunctivitis

Randomized open controlled clinical trial to evaluate the efficacy of drakshadi siddha dugdha aschyotana in pittaj abhishyanda with special reference to acute mucopurulent conjunctivitis. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/10/058659
Enrollment
84
Registered
2023-10-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-10-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H100- Mucopurulent conjunctivitis

Interventions

None listed

Sponsors

Dr Ketan Krishna Dhainje
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Shows symptoms of Acute Mucopurulent Conjunctivitis 2 Patient with age above 18 years 3 Patient irrespective of Gender educational socioeconomic marital and caste status

Exclusion criteria

Exclusion criteria: 1 Any other active acute infective ocular disease 2 Recently operated eye 3 Patient having systemic disease

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of Drakshadi Siddha Dugdha Aschyotana in Pittaj Abhishyanada with special reference to Acute Mucopurulent Conjunctivitis.Timepoint: 4 weeks

Secondary

MeasureTime frame
To review the literature of Pittaj Abhishyanda & Acute Mucopurulent Conjunctivitis. To study the adverse effects of Drakshadi Siddha Dugdha Ashchyotana in Pittaj Abhishyanda with special reference to Acute Mucopurulent Conjunctivitis if there any.Timepoint: 4 weeks

Countries

India

Contacts

Public ContactDr Pournima Fasale

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate and Research Center Ashta

pournimafasale33@gmail.com9373079219

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026